Background: With the success of recent non-viral gene delivery-based COVID-19 vaccines, nanovectors have gained some public acceptance and come to the forefront of advanced therapies. Unfortunately, the relatively low ability of the vectors to overcome cellular barriers adversely affects their effectiveness. Scientists have thus been striving to develop ever more effective gene delivery vectors, but the results are still far from satisfactory. Therefore, developing novel strategies is probably the only way forward to bring about genuine change. Herein, we devise a brand-new gene delivery strategy to boost dramatically the transfection efficiency of two gold standard nucleic acid (NA)/polymer nanoparticles (polyplexes) in vitro. Results: We...
INTRODUCTION: The main challenge of gene delivery is the design of effective and non-cytotoxic non-v...
Purpose/Objectives: One major drawback of non-viral gene delivery means stands in the lack of suitab...
Introduction: In the past decades, the rise of nanotechnology has brought new hope for the developme...
Background: With the success of recent non-viral gene delivery-based COVID-19 vaccines, nanovectors ...
Introduction Despite the recent success of COVID-19 vaccines, the use of non-viral carriers, namely...
Introduction: Non-viral gene delivery strategies emerged as a new breakthrough for clinical and rese...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
The main challenge of non-viral gene delivery is the design of effective and non-cytotoxic vectors a...
INTRODUCTION: The major drawback in the use of non-viral means for gene delivery purposes stands in ...
Introduction Since their first introduction, non-viral vectors for gene delivery purposes have made...
Gene delivery is the transfer of genetic material into recipient cells to alter some functions. As t...
Introduction Gene therapy is a promising strategy for the treatment of genetic disorders. In this c...
Introduction: Non-viral gene delivery employs positively charged lipidic or polymeric vectors to dri...
INTRODUCTION: The main challenge of gene delivery is the design of effective and non-cytotoxic non-v...
Purpose/Objectives: One major drawback of non-viral gene delivery means stands in the lack of suitab...
Introduction: In the past decades, the rise of nanotechnology has brought new hope for the developme...
Background: With the success of recent non-viral gene delivery-based COVID-19 vaccines, nanovectors ...
Introduction Despite the recent success of COVID-19 vaccines, the use of non-viral carriers, namely...
Introduction: Non-viral gene delivery strategies emerged as a new breakthrough for clinical and rese...
Introduction: In the past decades, the rise of nanotechnology and gene therapy have brought new hop...
The main challenge of non-viral gene delivery is the design of effective and non-cytotoxic vectors a...
INTRODUCTION: The major drawback in the use of non-viral means for gene delivery purposes stands in ...
Introduction Since their first introduction, non-viral vectors for gene delivery purposes have made...
Gene delivery is the transfer of genetic material into recipient cells to alter some functions. As t...
Introduction Gene therapy is a promising strategy for the treatment of genetic disorders. In this c...
Introduction: Non-viral gene delivery employs positively charged lipidic or polymeric vectors to dri...
INTRODUCTION: The main challenge of gene delivery is the design of effective and non-cytotoxic non-v...
Purpose/Objectives: One major drawback of non-viral gene delivery means stands in the lack of suitab...
Introduction: In the past decades, the rise of nanotechnology has brought new hope for the developme...